Literature DB >> 29183719

The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals.

Ahmed Diab1, Adrien Foca2, Fabien Zoulim3, David Durantel4, Ourania Andrisani5.   

Abstract

Virally encoded proteins have evolved to perform multiple functions, and the core protein (HBc) of the hepatitis B virus (HBV) is a perfect example. While HBc is the structural component of the viral nucleocapsid, additional novel functions for the nucleus-localized HBc have recently been described. These results extend for HBc, beyond its structural role, a regulatory function in the viral life cycle and potentially a role in pathogenesis. In this article, we review the diverse roles of HBc in HBV replication and pathogenesis, emphasizing how the unique structure of this protein is key to its various functions. We focus in particular on recent advances in understanding the significance of HBc phosphorylations, its interaction with host proteins and the role of HBc in regulating the transcription of host genes. We also briefly allude to the emerging niche for new direct-acting antivirals targeting HBc, known as Core (protein) Allosteric Modulators (CAMs).
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CAMs; Core allosteric modulators; HBV; HBV core antigen; HBc; HBc phosphorylations; HBc structure; Hepatitis B virus; PLK1

Mesh:

Substances:

Year:  2017        PMID: 29183719      PMCID: PMC5757518          DOI: 10.1016/j.antiviral.2017.11.015

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  115 in total

1.  Phosphoacceptors threonine 162 and serines 170 and 178 within the carboxyl-terminal RRRS/T motif of the hepatitis B virus core protein make multiple contributions to hepatitis B virus replication.

Authors:  Jaesung Jung; Seong Gyu Hwang; Yong-Joon Chwae; Sun Park; Ho-Joon Shin; Kyongmin Kim
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

Review 2.  CREB-mediated transcriptional control.

Authors:  O M Andrisani
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1999       Impact factor: 1.807

3.  Reverse transcription-associated dephosphorylation of hepadnavirus nucleocapsids.

Authors:  David H Perlman; Eric A Berg; Peter B O'connor; Catherine E Costello; Jianming Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-10       Impact factor: 11.205

Review 4.  Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure.

Authors:  Julie Lucifora; Ulrike Protzer
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

5.  Negative regulation of hepatitis B virus replication by cellular Hsp40/DnaJ proteins through destabilization of viral core and X proteins.

Authors:  Sook-Young Sohn; Sun-Bum Kim; Joon Kim; Byung-Yoon Ahn
Journal:  J Gen Virol       Date:  2006-07       Impact factor: 3.891

6.  Immunohistochemistry for core and surface antigens in chronic hepatitis.

Authors:  R R Sharma; R K Dhiman; Y Chawla; R K Vasistha
Journal:  Trop Gastroenterol       Date:  2002 Jan-Mar

7.  Human papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2.

Authors:  Emma L Prescott; Claire L Brimacombe; Margaret Hartley; Ian Bell; Sheila Graham; Sally Roberts
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

8.  A kinase chaperones hepatitis B virus capsid assembly and captures capsid dynamics in vitro.

Authors:  Chao Chen; Joseph Che-Yen Wang; Adam Zlotnick
Journal:  PLoS Pathog       Date:  2011-11-17       Impact factor: 6.823

Review 9.  Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application.

Authors:  Jianming Hu; Kuancheng Liu
Journal:  Viruses       Date:  2017-03-21       Impact factor: 5.048

10.  Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses.

Authors:  Inci Aydin; Susanne Weber; Berend Snijder; Pilar Samperio Ventayol; Andreas Kühbacher; Miriam Becker; Patricia M Day; John T Schiller; Michael Kann; Lucas Pelkmans; Ari Helenius; Mario Schelhaas
Journal:  PLoS Pathog       Date:  2014-05-29       Impact factor: 6.823

View more
  35 in total

1.  Discovery of a New Sulfonamide Hepatitis B Capsid Assembly Modulator.

Authors:  Hyo Gyeong Na; Ali Imran; Kyuneun Kim; Hong Sik Han; Young Jin Lee; Myung-Jin Kim; Chang-Soo Yun; Young-Sik Jung; Joo-Youn Lee; Soo Bong Han
Journal:  ACS Med Chem Lett       Date:  2020-01-09       Impact factor: 4.345

Review 2.  Hepatitis B: Current Status of Therapy and Future Therapies.

Authors:  Elias Spyrou; Coleman I Smith; Marc G Ghany
Journal:  Gastroenterol Clin North Am       Date:  2020-03-29       Impact factor: 3.806

3.  Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma.

Authors:  Saravana Kumar Kailasam Mani; Ourania Andrisani
Journal:  Cytokine       Date:  2018-08-17       Impact factor: 3.861

4.  Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation.

Authors:  Nagraj Mani; Andrew G Cole; Janet R Phelps; Andrzej Ardzinski; Kyle D Cobarrubias; Andrea Cuconati; Bruce D Dorsey; Ellen Evangelista; Kristi Fan; Fang Guo; Haitao Guo; Ju-Tao Guo; Troy O Harasym; Salam Kadhim; Steven G Kultgen; Amy C H Lee; Alice H L Li; Quanxin Long; Sara A Majeski; Richeng Mao; Kevin D McClintock; Stephen P Reid; Rene Rijnbrand; Nicholas M Snead; Holly M Micolochick Steuer; Kim Stever; Sunny Tang; Xiaohe Wang; Qiong Zhao; Michael J Sofia
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 5.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

6.  Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379.

Authors:  Jan Martin Berke; Pascale Dehertogh; Karen Vergauwen; Wendy Mostmans; Koen Vandyck; Pierre Raboisson; Frederik Pauwels
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

7.  Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.

Authors:  Lu Ruan; Jodi A Hadden; Adam Zlotnick
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

8.  Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.

Authors:  Thomas Lahlali; Jan Martin Berke; Karen Vergauwen; Adrien Foca; Koen Vandyck; Frederik Pauwels; Fabien Zoulim; David Durantel
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

9.  Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses In Vitro and in Humanized Mice.

Authors:  Franck Amblard; Sebastien Boucle; Leda Bassit; Bryan Cox; Ozkan Sari; Sijia Tao; Zhe Chen; Tugba Ozturk; Kiran Verma; Olivia Russell; Virgile Rat; Hugues de Rocquigny; Oriane Fiquet; Maud Boussand; James Di Santo; Helene Strick-Marchand; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

10.  Effect of Plasma Protein Binding on the Anti-Hepatitis B Virus Activity and Pharmacokinetic Properties of NVR 3-778.

Authors:  Nicky Helsen; Tom Vervoort; Joris Vandenbossche; Oliver Lenz; Mario Monshouwer; Frederik Pauwels; Jan Snoeys
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.